Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EVOLOCUMAB Cause Blood glucose increased? 1,587 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,587 reports of Blood glucose increased have been filed in association with EVOLOCUMAB (REPATHA). This represents 1.1% of all adverse event reports for EVOLOCUMAB.

1,587
Reports of Blood glucose increased with EVOLOCUMAB
1.1%
of all EVOLOCUMAB reports
2
Deaths
69
Hospitalizations

How Dangerous Is Blood glucose increased From EVOLOCUMAB?

Of the 1,587 reports, 2 (0.1%) resulted in death, 69 (4.3%) required hospitalization, and 5 (0.3%) were considered life-threatening.

Is Blood glucose increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 1,587 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606) Back pain (5,254) Myalgia (5,061) Drug dose omission (4,914) Injection site bruising (4,409)

What Other Drugs Cause Blood glucose increased?

INSULIN LISPRO (31,969) INSULIN GLARGINE (19,234) DULAGLUTIDE (9,119) INSULIN HUMAN (8,704) INSULIN ASPART (4,743) METFORMIN (4,038) EXENATIDE (3,363) INSULIN DEGLUDEC (2,644) SEMAGLUTIDE (2,240) TIRZEPATIDE (2,240)

Which EVOLOCUMAB Alternatives Have Lower Blood glucose increased Risk?

EVOLOCUMAB vs EXELON EVOLOCUMAB vs EXEMESTANE EVOLOCUMAB vs EXENATIDE EVOLOCUMAB vs EXFORGE EVOLOCUMAB vs EXJADE

Related Pages

EVOLOCUMAB Full Profile All Blood glucose increased Reports All Drugs Causing Blood glucose increased EVOLOCUMAB Demographics